VANCOUVER, BC — NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces that… Read More
Company’s recent recruitment strategy change has resulted in an unprecedented level of inquiries regarding potential study participation – Transplantation of islets into the enhanced 10-channel Cell Pouch is anticipated in… Read More
UBRELVY® is the first and only oral CGRP receptor antagonist (gepant) approved by Health Canada for the acute treatment of migraine UBRELVY® was demonstrated to reduce or eliminate migraine pain with… Read More
PharmAla will be the exclusive global reseller of Mindset’s cGMP psilocybin to appropriately licensed clinical researchers VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on… Read More
